Clinical trial
Real-world Patient Profile and Treatment Persistence of Ocrelizumab in Multiple Sclerosis: A Retrospective Analysis in Latin America
NCT03784547 is registered in ClinicalTrials.gov with Hospital Italiano de Buenos Aires as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Real-world Patient Profile and Treatment Persistence of Ocrelizumab in Multiple Sclerosis: A Retrospective Analysis in Latin America
- Lead sponsor
- Hospital Italiano de Buenos Aires
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 1, 2019
- Completion date
- September 1, 2019
- Enrollment
- 100 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.